K C Balaji

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Human Immunodeficiency Virus

Tyrosine Kinase

Prostate Cancer

Top Venues

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Sanjeev Shukla, Steven Fletcher, Jay Chauhan, Victor Chalfant, Carlos Riveros, Yuri Mackeyev, Pankaj Kumar Singh, Sunil Krishnan, Teruko Osumi, K C Balaji
3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth. Cancer gene therapy 29 (11) (2022)